Oragenics, Inc.

OGEN · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3-$2-$2-$3
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0-$0$0
Change in WC-$1$0-$0$1
Other Non-Cash$1$1$0$0
Operating Cash Flow-$3-$1-$2-$2
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0-$0$2-$0
Stock Issued$0$0$3$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$12$0$0$0
Financing Cash Flow$12-$0$5-$0
Forex Effect$0$0$0$0
Net Chg. in Cash$9-$1$3-$2
Supplemental Information
Beg. Cash$2$3$1$3
End Cash$11$2$3$1
Free Cash Flow-$3-$1-$2-$2
Oragenics, Inc. (OGEN) Financial Statements & Key Stats | AlphaPilot